Amedisys has been among the many home health and hospice providers taking financial and operational hits as the coronavirus pandemic continues its spread, Hospice News reports. Despite facing headwinds, the company remains steadfast in its position on hospice as it seeks to further build up its presence in the market. Read more.
Related Posts
Exclusive: How Medical Practices can Handle Growing Regulatory Pressure
According the most recent MGMA study that explored regulatory burdens in detail, surprise billing, prior authorization, the Merit-Based Incentive Payment System (MIPS), audits and appeals, and Medicare advantage chart audits were among the top regulatory issues most burdensome for medical practices. Over 60% of respondents called them “extremely burdensome.”
November 4, 2022
Not Time to ‘Pull Back’: UPMC, Mass General, Penn Leaders on Innovation in ’23
Economic pressures such as rising interest rates and bank failures make it even more imperative to reshape healthcare, but in a more focused way.
March 27, 2023
Health Benefits Managers are Prioritizing Behavioral Health. Here’s What that Means for the Industry
Behavioral health-related conditions such as depression, anxiety, addiction and others are among the largest drivers in health care.
October 6, 2022
Modivcare Forecasts Major Growth in Personal Care, Further Benefits From Value-Based Contracts
The Denver-based Modivcare offers technology-enabled health care services and provides non-emergency medical transportation.
December 7, 2022